TPA
EW icon

Trivium Point Advisory’s Edwards Lifesciences EW Stock Holding History

Trivium Point Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,893
Closed -$267K – 335
2024
Q2 		$267K Buy
2,893
+388
+15% +$34.4K 0.04% 264
2024
Q1 		$239K Sell
2,505
-803
-24% -$67.5K 0.05% 198
2023
Q4 		$252K Sell
3,308
-21,765
-87% -$1.51M 0.06% 179
2023
Q3 		$1.75M Sell
25,073
-5,007
-17% -$402K 0.48% 70
2023
Q2 		$2.84M Sell
30,080
-718
-2% -$62.4K 0.77% 39
2023
Q1 		$2.55M Buy
30,798
+1,022
+3% +$80.3K 0.69% 43
2022
Q4 		$2.29M Sell
29,776
-297
-1% -$22.9K 0.67% 46
2022
Q3 		$2.6M Buy
30,073
+385
+1% +$37K 0.81% 35
2022
Q2 		$2.92M Sell
29,688
-72
-0.2% -$7.45K 0.88% 30
2022
Q1 		$3.58M Sell
29,760
-13,117
-31% -$1.47M 0.8% 35
2021
Q4 		$5.55M Buy
42,877
+70
+0.2% +$8.16K 1.17% 20
2021
Q3 		$4.75M Sell
42,807
-311
-0.7% -$35.5K 1.13% 19
2021
Q2 		$4.47M Buy
43,118
+3,094
+8% +$292K 1.11% 18
2021
Q1 		$3.35M Buy
40,024
+4,319
+12% +$365K 0.91% 19
2020
Q4 		$3.19M Buy
35,705
+1,665
+5% +$138K 0.92% 18
2020
Q3 		$2.72M Buy
34,040
+8,411
+33% +$656K 0.96% 21
2020
Q2 		$1.78M Buy
25,629
+2,547
+11% +$181K 0.71% 48
2020
Q1 		$1.59M Sell
23,082
-1,890
-8% -$136K 0.82% 46
2019
Q4 		$1.94M Sell
24,972
-1,845
-7% -$144K 0.75% 45
2019
Q3 		$2.01M Sell
26,817
-1,401
-5% -$98.4K 0.92% 38
2019
Q2 		$1.74M Buy
28,218
+936
+3% +$56.6K 0.77% 49
2019
Q1 		$1.74M Buy
27,282
+480
+2% +$27.4K 0.81% 43
2018
Q4 		$1.37M Buy
+26,802
New +$1.36M 0.83% 53

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Trivium Point Advisory's EW Position: Q3 2024 in Review

Trivium Point Advisory sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,893 shares — an estimated $267K sold.

Trivium Point Advisory first reported a position in EW in Q4 2018 and held it in 23 quarters. The position peaked at $5.55M in Q4 2021. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Trivium Point Advisory reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Trivium Point Advisory sold 2,893 Edwards Lifesciences shares in Q3 2024, an estimated $267K.
  • Trivium Point Advisory first reported a position in Edwards Lifesciences in Q4 2018 and held it in 23 quarters.
  • Trivium Point Advisory's Edwards Lifesciences position peaked at $5.55M in Q4 2021.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Trivium Point Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.